Chaga Mushroom Antioxidant Capacity
When the United States Department of Agriculture (USDA) maintained its Oxygen Radical Absorbance Capacity (ORAC) database between roughly 2007 and 2012, chaga sclerotium consistently scored the highest of any tested foodstuff — approximately 36,000 µmol Trolox equivalents per gram, dramatically higher than acai berries (~1,500), wild blueberries (~95), or dark chocolate (~210). That number is the headline statistic most often quoted in chaga marketing literature, and it is technically accurate. But the U.S. Department of Agriculture withdrew its oxygen radical absorbance capacity database entirely in May 2012 with a published statement explaining that in-vitro radical-scavenging numbers do not translate predictably to in vivo cellular antioxidant defense, and that the food-industry use of oxygen radical absorbance capacity values had become "misleading" to consumers. This deep-dive explores both sides: the genuine biochemistry that makes chaga unusually antioxidant-rich (melanin pigment, superoxide dismutase (SOD) enzyme, betulinic acid, polyphenols) and the honest scientific limits of what oxygen radical absorbance capacity numbers actually mean.
Table of Contents
- The 36,000 Oxygen Radical Absorbance Capacity Headline and What It Originally Meant
- The U.S. Department of Agriculture Database Withdrawal (May 2012) and Its Reasoning
- Melanin Pigment as a Polyphenolic Antioxidant Polymer
- Superoxide Dismutase (SOD) Enzyme Content
- Betulinic Acid and the Birch-Triterpene Contribution
- Small Polyphenols and a Triterpenoid (Caffeic Acid Derivatives, Hispidin, Inotodiol)
- In-Vitro Radical Scavenging vs In-Vivo Cellular Defense
- The Nrf2 / ARE Pathway and Inducible Antioxidant Defense
- Clinical Relevance: Where the Evidence Is and Is Not
- Honest Summary: Genuinely Unusual, Not Magic
- Key Research Papers
- Connections
- Featured Videos
The 36,000 Oxygen Radical Absorbance Capacity Headline and What It Originally Meant
The Oxygen Radical Absorbance Capacity (ORAC) assay was described by Guohua Cao and colleagues at the Gerontology Research Center of the National Institute on Aging (part of the U.S. National Institutes of Health) in Baltimore, in a paper published in 1993. The procedure measures how effectively a food extract neutralizes peroxyl radicals generated in vitro by thermal decomposition of an azo-initiator compound (typically AAPH). The result is expressed in micromoles of Trolox equivalents per gram of dry material (µmol TE/g), where Trolox is a water-soluble vitamin E analog used as the reference standard.
The U.S. Department of Agriculture published an oxygen radical absorbance capacity reference database starting in 2007. Chaga sclerotium was added to the database based on independent published assays, and the reported value of approximately 36,000-37,000 µmol TE/g made chaga the highest-ORAC foodstuff in the entire database. For comparison, the top-tier "antioxidant superfoods" all clustered in the 1,500-4,000 range (acai 1,500, goji berries 3,300). Chaga was an outlier by an order of magnitude.
The mechanistic interpretation of this high value involves three factors:
- The dense melanin coat — chaga's black exterior is a polyphenolic polymer with extensive conjugated double bonds, ideal for absorbing peroxyl radicals.
- The betulinic acid concentration — chaga contains the triterpenes betulinic acid and betulin (the same compounds found in birch bark), which contribute to the assay value.
- Small polyphenols — chaga contains caffeic acid derivatives and hispidin (a pyranone polyphenol unique to Inonotus and Phellinus), alongside the triterpenoid inotodiol, all contributing additively.
So the 36,000 number is not fraudulent or invented; it reflects a real and unusual chemical composition. The question is how meaningful that in-vitro assay value is for human biology.
The U.S. Department of Agriculture Database Withdrawal (May 2012) and Its Reasoning
In May 2012, the U.S. Department of Agriculture's Nutrient Data Laboratory formally removed the oxygen radical absorbance capacity database from its public website with this published explanation: "oxygen radical absorbance capacity values are routinely misused by food and dietary supplement manufacturing companies to promote their products and by consumers to guide their food and dietary supplement choices. There is no evidence that the beneficial effects of polyphenol-rich foods can be attributed to the antioxidant properties of these foods. The data for antioxidant capacity of foods generated by in vitro (test-tube) methods cannot be extrapolated to in vivo (human) effects."
The reasons behind this withdrawal are scientifically important and worth understanding:
- Bioavailability is poor — most polyphenols that score high on the oxygen radical absorbance capacity assay are very poorly absorbed when consumed orally. Estimates of polyphenol bioavailability range from less than 1% to about 10% depending on the compound, the food matrix, and the gut microbiota. The peak plasma concentrations achievable from oral consumption are typically 100-1000 times lower than the concentrations used in the in-vitro oxygen radical absorbance capacity assay.
- Polyphenols are metabolized rapidly — what little is absorbed is mostly converted to glucuronide and sulfate conjugates by phase-II liver enzymes, and these conjugates often have very different (usually much lower) antioxidant activity than the parent compound.
- The body has its own antioxidant systems — the cellular antioxidant defense is dominated by glutathione (millimolar intracellular concentrations), the superoxide dismutase/catalase/glutathione-peroxidase enzymatic cascade, and the Nrf2-induced phase-II detoxification enzymes. Adding micromolar concentrations of dietary polyphenols to this background changes very little in direct radical scavenging.
- The bigger story is signaling, not direct scavenging — the modern understanding of polyphenol health benefits emphasizes their role as signaling molecules (Nrf2 activation, NF-kappa-B inhibition, sirtuin activation) rather than as direct radical scavengers. The oxygen radical absorbance capacity assay does not measure this signaling activity.
- Inflated marketing claims — the food and supplement industry was making increasingly aggressive disease-prevention claims based purely on oxygen radical absorbance capacity values, with no clinical evidence to support them. The U.S. Department of Agriculture withdrew the database in part to deny these marketers a scientific veneer.
The withdrawal does not mean that chaga's antioxidant content is fake or that oxygen radical absorbance capacity values are meaningless — they remain useful for comparative chemistry of different food samples and for tracking processing effects. But it does mean that the simple inference "high oxygen radical absorbance capacity = good for you" was not supported, and the chaga marketing claim "highest oxygen radical absorbance capacity of any food therefore most powerful antioxidant for human health" is not scientifically justified.
Melanin Pigment as a Polyphenolic Antioxidant Polymer
The visibly distinctive feature of wild chaga is its near-black, charred-charcoal-looking exterior. This color comes from melanin — the same pigment family that produces skin pigmentation in humans and color in many fungi and bacteria. Chaga melanin is chemically a heteropolymer of oxidized phenolic monomers (chemically related to but distinct from human eumelanin), produced as a defensive secondary metabolite by the fungus.
Fungal melanins have several biological functions for the fungus itself: protection against ultraviolet (UV) radiation (relevant for chaga exposed to sun on the side of a birch), protection against oxidative damage from the host tree's defensive response, and structural reinforcement of the cell wall. From a human-consumption standpoint, melanin's polyphenolic structure with extensive conjugated double bonds makes it a potent radical scavenger in the in-vitro setting.
The interesting wrinkle: chaga melanin is largely insoluble in water at neutral pH (it dissolves in alkaline conditions and in some organic solvents). When you steep chaga in hot water for traditional tea preparation, only a fraction of the melanin extracts; much remains in the spent chunks. Some practitioners boil the chunks longer (or use a pressure cooker, a "Russian samovar" technique) to extract more melanin; the resulting decoction is darker.
The melanin fraction of chaga has not been well studied for human bioavailability. Animal studies suggest that orally consumed melanin survives gastric digestion in part (intact melanin appears in feces), and a fraction is absorbed and excreted in urine. Whether absorbed melanin retains antioxidant activity in vivo, or simply acts as an inert excreted compound, is not yet clearly established.
Superoxide Dismutase (SOD) Enzyme Content
Superoxide dismutase (SOD) is one of the body's primary endogenous antioxidant enzymes. It catalyzes the conversion of the superoxide radical (O2·-) to hydrogen peroxide (H2O2), which catalase then converts to water plus oxygen. The superoxide dismutase/catalase enzyme cascade is the principal cellular defense against oxidative damage from mitochondrial electron transport, from immune-cell respiratory burst, and from environmental oxidant exposure.
Chaga sclerotium contains genuine superoxide dismutase enzyme protein. Multiple analytical studies have measured superoxide dismutase activity in chaga extracts in the range of 5,000-35,000 superoxide dismutase units per gram of dry weight, depending on extraction method and source. This is a substantial amount — it is comparable to or higher than the superoxide dismutase content of other "high-SOD" foods like cantaloupe extract (a common superoxide dismutase supplement source).
The clinical relevance of orally consumed superoxide dismutase is debated. Protein enzymes are typically denatured by gastric acid and proteolytically digested in the small intestine, so the conventional pharmacology would predict that swallowed superoxide dismutase provides only the amino acids of the superoxide dismutase protein after digestion — not active enzyme. However:
- Some studies suggest that enteric-coated or specially formulated superoxide dismutase supplements can survive gastric digestion and produce measurable physiological effects.
- The Nrf2 signaling pathway can be triggered by low doses of oral superoxide dismutase, indirectly increasing endogenous superoxide dismutase production. This is one of the proposed mechanisms for superoxide dismutase supplements that do not appear to be substantially bioavailable as intact protein.
- Some of the superoxide dismutase activity in chaga decoctions may come from non-protein chemistry — certain low-molecular-weight chaga compounds have intrinsic superoxide dismutase-mimetic activity in vitro.
The honest summary: chaga's superoxide dismutase content is real and unusual among foods, but the in-vivo translation of orally consumed superoxide dismutase is genuinely uncertain, and the evidence does not support strong claims for chaga's superoxide dismutase activity.
Betulinic Acid and the Birch-Triterpene Contribution
The chaga story is genuinely unusual among medicinal mushrooms because chaga, a parasite of the birch host tree (Betula pendula, Betula pubescens, Betula papyrifera in North America), contains the same family of compounds that its host is known for. Birch bark synthesizes large quantities of pentacyclic triterpenoids — betulin (the white powdery compound that gives birch bark its color and weatherproofing) and the smaller quantity of betulinic acid (the oxidized form). These triterpenoids are part of the birch tree's defensive chemistry against bark-eating animals and decay fungi.
Chaga produces its own triterpenes (betulin, betulinic acid, inotodiol); the amounts differ by host tree. A 2025 genome study titled “Independent evolution of betulin biosynthesis in Inonotus obliquus” assembled a 50.7 Mbp chaga genome and found a whole-genome duplication about 1.3 million years ago that kept many cytochrome P450 genes (a large family of enzyme genes) and raised the variety of the fungus's chemistry; chemical fingerprinting confirmed more complex terpene-making chemistry than in related fungi without that duplication. The authors suggest this may have arisen from co-evolution with birch, which evolved high betulin content in its bark 4–8 million years ago. A 2022 Estonian study that measured wild chaga conks found betulin at 111 to 159 µg/g in conks from grey alder (Alnus incana) and silver birch (Betula pendula), and betulinic acid at 20–132 µg/g in the birch conks. These compounds contribute to chaga's antioxidant capacity (betulinic acid has measurable radical-scavenging activity in vitro) and to its anti-inflammatory and pro-apoptotic effects (see the Cancer Research deep-dive).
This is also why chaga sourced from a non-birch host (occasionally Inonotus obliquus grows on alder, elm, or beech, and the resulting sclerotium is sometimes harvested and sold) is chemically different from canonical birch-host chaga, though not in the way often assumed. In the 2022 Estonian study, conks from alder also contained betulin, and they had significantly (p < 0.05) more betulinic acid than birch conks: 474–635 versus 20–132 µg/g. Inotodiol was quite similar in the two (7455–8961 µg/g on alder, 7881–9057 µg/g on birch), while the birch conks were richer in total polyphenols, flavonols and glucans. Quality-conscious producers and Russian traditional users insist on birch-host chaga only.
Cultivated chaga (grown on artificial substrate or in submerged liquid culture) has no host tree and is a different preparation from wild conks; it still has the fungal beta-glucan immune-modulating activity. The older idea that it must lack betulinic acid because there is no birch bark to draw from does not fit the 2025 genome study, which reports that chaga evolved its own betulin-making chemistry. The 2022 Estonian measurements were made on wild conks, so they do not show how much a given cultivated product contains.
Small Polyphenols and a Triterpenoid (Caffeic Acid Derivatives, Hispidin, Inotodiol)
Beyond melanin and the triterpenoids, chaga contains several smaller polyphenols and phenolic acids, plus the triterpenoid inotodiol, that contribute to the antioxidant profile:
- Caffeic acid and its derivatives — standard plant-kingdom phenolic acid, contributes additively to oxygen radical absorbance capacity and is reasonably well absorbed.
- Hispidin — a yellow pyranone polyphenol relatively unique to Inonotus and Phellinus mushroom genera. Strong radical scavenger in vitro, less studied for in-vivo activity.
- Inotodiol — a lanostane-type triterpenoid named after Inonotus. Shows antioxidant, anti-inflammatory, and pro-apoptotic activity in cell-culture studies. A 2022 Estonian study measured 7455–8961 µg/g in conks from alder and 7881–9057 µg/g in conks from birch.
- Trametenolic acid and other lanostane triterpenoids — structural cousins of inotodiol, contribute to the antifungal-derived triterpene fraction.
- Polyphenolic small molecules — chaga also contains gallic acid, syringic acid, vanillic acid, and 3,4-dihydroxybenzaldehyde in smaller amounts.
The combined small-polyphenol fraction is a significant contributor to the chaga oxygen radical absorbance capacity value and likely accounts for a meaningful share of any in-vivo cellular antioxidant signaling activity (Nrf2 induction, NF-kappa-B inhibition).
A 2005 laboratory study (Cui and colleagues) tested four chaga extracts. The polyphenol extract had strong antioxidant activity against three kinds of free radicals and also protected human skin cells (the HaCaT keratinocyte cell line) from hydrogen-peroxide stress in a dish. The extract containing triterpenoids and steroids had a relatively strong antioxidant effect in the test tube but did not protect the cells, and the polysaccharide extract was inactive. The authors report that chaga scavenges free radicals at concentrations higher than 5 µg/ml. In this study, scavenging radicals in a test tube and protecting living cells did not always go together.
In-Vitro Radical Scavenging vs In-Vivo Cellular Defense
The single most important conceptual point in this entire topic is the gap between in-vitro radical scavenging assays (ORAC, DPPH, FRAP, TEAC) and in-vivo cellular antioxidant defense. The two are related but not identical, and confusing them is the source of most of the over-claiming in the antioxidant-supplement literature.
In-vitro radical scavenging measures how rapidly a test compound reacts with a chemically generated free radical in a test tube. The assay is performed at compound concentrations of typically 10-100 micromolar — far higher than any concentration achievable in human plasma from oral consumption. A high oxygen radical absorbance capacity value tells you that the compound can react with peroxyl radicals if present at that concentration.
In-vivo cellular antioxidant defense is dominated by intracellular glutathione (3-10 millimolar in most cells), the superoxide dismutase/catalase/glutathione-peroxidase enzyme cascade, the thioredoxin system, the peroxiredoxins, and the Nrf2-induced phase-II detoxification enzymes. Dietary polyphenols at the low-micromolar plasma concentrations achievable from realistic intake contribute very little to direct radical scavenging against this background.
Where dietary polyphenols do appear to matter in vivo is as signaling molecules that activate the body's own endogenous antioxidant systems — particularly through the Keap1-Nrf2-ARE pathway (next section). This is a fundamentally different mechanism from direct radical scavenging, and it operates at much lower concentrations than the direct-scavenging mechanism would require.
So the right question about chaga is not "how high does it score on oxygen radical absorbance capacity" but "does consuming chaga increase the activity of the body's endogenous antioxidant defense?" That question has some preliminary supportive evidence (chaga extracts induce Nrf2-target gene expression in cell culture, and animal studies show induction of liver glutathione and superoxide dismutase activity after chaga supplementation), but the human evidence is limited.
The Nrf2 / ARE Pathway and Inducible Antioxidant Defense
Nuclear factor erythroid-2 related factor 2 (Nrf2) is a transcription factor that, under conditions of oxidative or electrophilic stress, translocates to the nucleus and binds antioxidant response elements (AREs) in the promoter regions of more than 200 cytoprotective genes. The Nrf2-target gene set includes:
- Glutathione synthesis enzymes (gamma-glutamylcysteine ligase catalytic and modifier subunits)
- Glutathione-S-transferases
- NAD(P)H quinone dehydrogenase 1 (NQO1)
- Heme oxygenase 1 (HO-1)
- Superoxide dismutase isoforms
- Catalase
- Thioredoxin reductase
- Multiple phase-II xenobiotic detoxification enzymes
Activation of Nrf2 is currently the central paradigm in chemoprevention and in mechanisms of dietary polyphenol action. Compounds that activate Nrf2 at low concentrations (sulforaphane from broccoli sprouts is the canonical example; curcumin, resveratrol, epigallocatechin gallate (EGCG) from green tea, and many others) shift cellular antioxidant defense upward in a coordinated, multi-enzyme way that no exogenous radical scavenger can match.
Chaga extracts and several individual chaga compounds (betulinic acid, inotodiol, hispidin) have been documented in cell-culture studies to induce Nrf2 nuclear translocation and upregulate Nrf2-target genes. Animal studies show parallel increases in tissue glutathione, superoxide dismutase activity, and HO-1 expression after chaga supplementation. This Nrf2-inducer activity is, in current scientific understanding, the most likely mechanism by which chaga actually produces meaningful in-vivo antioxidant effect — not its high oxygen radical absorbance capacity score.
For more on oxidative stress as a clinical problem and on the strategies to address it, see our Oxidative Stress page.
Clinical Relevance: Where the Evidence Is and Is Not
What the evidence actually supports for chaga's antioxidant activity in human beings:
- Supported by reasonable evidence: chaga extracts induce Nrf2-target gene expression in cell culture and in animal models; chaga supplementation increases tissue glutathione and superoxide dismutase activity in animals; chaga reduces markers of oxidative DNA damage in lymphocytes from inflammatory bowel disease patients (ex-vivo treatment in the Najafzadeh 2007 study). In that study, white blood cells (lymphocytes) from 20 inflammatory bowel disease patients and 20 healthy volunteers were exposed to hydrogen peroxide in the test tube; adding chaga extract cut the hydrogen-peroxide DNA damage by 54.9% in the patient group and 34.9% in the healthy group. The people did not drink chaga in this study; their cells were treated in a dish.
- Plausible but not yet demonstrated: chaga consumption reduces clinical disease endpoints driven by chronic oxidative stress (atherosclerosis, neurodegenerative disease, age-related macular degeneration, several cancers). The mechanism is plausible; the clinical-trial evidence is essentially absent.
- Not supported by current evidence: specific therapeutic claims for chaga as treatment for any oxidative-stress-mediated disease. The dosing is not standardized, the trials have not been done, and the marketing claims (often based on the now-withdrawn oxygen radical absorbance capacity database) are not scientifically justified.
A documented kidney risk. Chaga is very high in oxalate, and doctors have reported kidney damage from oxalate crystals (oxalate nephropathy) in long-term chaga users. In a 2014 case report, a 72-year-old Japanese woman who had taken chaga powder (4–5 teaspoons per day) for 6 months for liver cancer lost kidney function and was started on hemodialysis; oxalate crystals were found in her kidney tissue and urine, and the authors describe it as the first reported case of oxalate nephropathy linked to chaga. In a 2020 case report from Korea, a 49-year-old man who had taken chaga powder for a long time for stubborn atopic dermatitis reached end-stage kidney disease, with oxalate crystal deposits in his kidney biopsy; the leftover chaga powder had an oxalate content of 14.2/100 g, which the authors call extremely high, and they describe chaga as a potential risk factor for chronic kidney disease.
The fair clinical positioning of chaga as an antioxidant is: it is a chemically unusual food with genuinely high in-vitro antioxidant content and biologically plausible Nrf2-inducer activity at oral doses, but the human-outcome evidence is preliminary and does not yet support specific disease-treatment claims. People interested in the medicinal-mushroom tradition use chaga as one part of a varied diet built on whole-plant polyphenol sources. The research does not show it can stand in for the antioxidant measures with stronger evidence behind them (lifestyle, smoking cessation, weight management, omega-3 intake, established antioxidant nutrients like vitamins C and E in appropriate context).
Honest Summary: Genuinely Unusual, Not Magic
Chaga is genuinely chemically unusual. The combination of dense melanin pigment, betulinic acid, real superoxide dismutase enzyme content, the polyphenol hispidin and the triterpenoid inotodiol, and beta-D-glucan polysaccharides produces a profile that no other food or medicinal mushroom matches exactly. The in-vitro antioxidant capacity is real, and the Nrf2-inducer signaling activity is biologically plausible at oral doses.
What it is not: a "miracle" antioxidant that, by virtue of its 36,000 oxygen radical absorbance capacity headline number, transforms human cellular antioxidant defense in a way that no other intervention can match. The oxygen radical absorbance capacity number reflects test-tube chemistry that does not translate directly to human plasma or tissue. The signaling-molecule story (Nrf2, NF-kappa-B) is the modern scientific frame and is more modest but more honest.
The traditional Russian use as a daily tonic, consumed for weeks to months at a time, is consistent with what we now understand mechanistically: slow induction of endogenous antioxidant defense rather than acute direct radical scavenging. On this reading, chaga fits the picture of a slow Nrf2-modulating tonic with a 500-year traditional-use history and a plausible (but not yet fully demonstrated) biological basis, rather than a high-ORAC antioxidant supplement.
Key Research Papers
- Cao G, Alessio HM, Cutler RG (1993). Oxygen-radical absorbance capacity assay for antioxidants. Free Radical Biology and Medicine 14(3):303-11. — PubMed PMID: 8458588
- Cui Y, Kim DS, Park KC (2005). Antioxidant effect of Inonotus obliquus. Journal of Ethnopharmacology 96(1-2):79-85. — PubMed PMID: 15588653
- Najafzadeh M, Reynolds PD, Baumgartner A, Jerwood D, Anderson D (2007). Chaga mushroom extract inhibits oxidative DNA damage in lymphocytes of patients with inflammatory bowel disease. Biofactors 31(3-4):191-200. — PubMed PMID: 18997282
- USDA Nutrient Data Laboratory withdrawal of ORAC database (2012) discussion — PubMed
- Shashkina MY, Shashkin PN, Sergeev AV (2006). Chemical and medicobiological properties of chaga (review). Pharmaceutical Chemistry Journal 40(10):560-568. — doi:10.1007/s11094-006-0194-4
- Babitskaia VG, Shcherba VV, Ikonnikova NV (2000). Melanin complex of the fungus Inonotus obliquus [article in Russian]. Prikl Biokhim Mikrobiol 36(4):439-44. — PubMed PMID: 10994193
- Glamočlija J, Ćirić A, Nikolić M, et al. (2015). Chemical characterization and biological activity of Chaga (Inonotus obliquus), a medicinal "mushroom". Journal of Ethnopharmacology 162:323-32. — PubMed PMID: 25576897
- Park YM, Won JH, Kim YH, et al. (2005). In vivo and in vitro anti-inflammatory and anti-nociceptive effects of the methanol extract of Inonotus obliquus. Journal of Ethnopharmacology 101(1-3):120-8. — PubMed PMID: 15905055
- Halliwell B (2007). Dietary polyphenols: good, bad, or indifferent for your health? Cardiovascular Research 73(2):341-7. — PubMed PMID: 17141749
- Surh YJ (2003). Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer 3(10):768-80. — PubMed PMID: 14570043
- Itoh K, Chiba T, Takahashi S, et al. (1997). An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochemical and Biophysical Research Communications 236(2):313-22. — PubMed PMID: 9240432
- Drenkhan R, Kaldmäe H, Silm M, Adamson K, Bleive U, Aluvee A, Erik M, Raal A (2022). Comparative Analyses of Bioactive Compounds in Inonotus obliquus Conks Growing on Alnus and Betula. Biomolecules 12(9):1178. — PubMed PMID: 36139017
- Safronov O, Bal GL, Sipari N, et al. (2025). Independent evolution of betulin biosynthesis in Inonotus obliquus. Scientific Reports 15(1):21319. — PubMed PMID: 40594539
- Kikuchi Y, Seta K, Ogawa Y, Takayama T, Nagata M, Taguchi T, Yahata K (2014). Chaga mushroom-induced oxalate nephropathy. Clinical Nephrology 81(6):440-4. — PubMed PMID: 23149251
- Lee S, Lee HY, Park Y, et al. (2020). Development of End Stage Renal Disease after Long-Term Ingestion of Chaga Mushroom: Case Report and Review of Literature. Journal of Korean Medical Science 35(19):e122. — PubMed PMID: 32419395